Type | Public (NYSE: FRX) |
---|---|
Industry | Pharmaceutical |
Founded | 1954 |
Headquarters | New York City, United States |
Key people | Howard Solomon, CEO |
Revenue | $4,419 million (2011)>[1] |
Employees | 5,600 |
Website | http://www.frx.com |
Forest Laboratories (NYSE: FRX) is a pharmaceutical company headquartered in New York City, US. The company's research and development spending has grown rapidly in recent years, and as of 2007, approached almost a billion US dollars a year, which put it on the list of the top 100 global corporations in R&D spending.[2][3] Forest Laboratories is also known for licensing European pharmaceuticals for sale in the United States.
Contents |
On 13 May 2010, ABC news and Bloomberg business news reported the organization "dodges taxes" by moving its profits offshore with the currently legal practice known as transfer pricing. U.S. Senator Carl Levin of Michigan has called transfer pricing "the corporate equivalent to secret offshore accounts of individual tax dodgers."[4]
In September 2010, Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. (a subsidiary of Forest Laboratories) agreed to pay more than $313 million to resolve allegations of civil and criminal liability relating to obstruction of justice, the distribution of an unapproved new drug, Levothroid, and the illegal promotion of Celexa for use in treating children and adolescents.[5]
Forest Laboratories has illegally promoted the drugs Celexa and Lexapro for unapproved pediatric uses in treating depression.[6]
Forest Laboratories has distributed Levothroid in violation of the Food, Drug, and Cosmetic Act (FDCA).[7]
Both Lexapro and Namenda are produced in bulk at the Forest plant in Dublin, Ireland, with secondary processing, such as bottling and blister-packing, being carried out in the USA at plants in New York and St. Louis. Corporate profits end up in Forest Labs' Bermuda "subsidiary", a facility that consists of a secretary in a law office in a country with no corporate tax.[8]
Some of the products Forest Laboratories markets with its partners include: